Study Evaluating Oral Administrations of HKI-272 in Healthy Male Subjects

An Open-Label, Single-Dose Study of the Mass Balance and Metabolic Disposition of Orally Administered [14C]-Labeled HKI-272 in Healthy Male Subjects

The purpose of this study is to evaluate the mass balance and metabolic distribution of C14-labeled HKI-272 in healthy male subjects.

Inclusion Criteria:

• Healthy male subjects, aged 18 to 50 years.

Exclusion Criteria:

• Female subjects